PRGF-Endoret

DEVICE2 trials

Sponsors

Biotechnology Institute IMASD

Conditions

Androgenetic AlopeciaNeurotrophic Keratitis

Phase 4

Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis

WithdrawnNCT02707120

Biotechnology Institute IMASDNeurotrophic Keratitis

Start: 2018-01-04End: 2020-01-31Updated: 2025-02-06

Unknown Phase

Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia

WithdrawnNCT01885676

Biotechnology Institute IMASDAndrogenetic Alopecia

Start: 2013-09-16End: 2017-12-18Updated: 2025-02-06